Dashboard
Manage Tickers

LEXX


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

lexaria-bioscience-hires-cro-to-oversee-12-week-study-on-dehydratech-glp-1-formulations-major-objectives-include-weight-loss-and-blood-sugar-reduction
Lexaria Bioscience Hires CRO To Oversee 12...
06/18/2024 13:06:53

lexaria-bioscience-announces-progress-in-human-pilot-study-glp-1-h24-2-second-round-of-dosing-completed-for-all-nine-participants-final-arm-expected-to-finish-by-early-july
Lexaria Bioscience Announces Progress In H...
06/05/2024 13:07:16

why-healthequity-shares-are-trading-higher-here-are-20-stocks-moving-premarket
Why HealthEquity Shares Are Trading Higher...
06/04/2024 09:50:06

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
05/30/2024 16:31:20

Core News & Articles
Lexaria Awards Contract To A CRO To Perfor...
05/23/2024 14:56:55

First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral formatKELOWNA, BC / ACCESSWIRE / M...

lexaria-granted-patent-21-compositions-and-methods-for-treating-hypertension-and-24-compositions-and-methods-for-treating-epilepsy
Lexaria Granted Patent #21: Compositions a...
05/21/2024 13:32:32

lexaria-bioscience-begins-dosing-in-glp-1-animal-study
Lexaria Bioscience Begins Dosing In GLP-1 ...
05/17/2024 13:12:19

Core News & Articles
Lexaria Announces New Research Program To ...
05/06/2024 13:08:30

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug d...

Core News & Articles
Lexaria To Receive $4.7M Gross Proceeds In...
04/30/2024 19:53:35

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug d...

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/16/2024 20:31:56

Core News & Articles
Lexaria Receives Ethics Review Board Appro...
04/16/2024 13:17:08

Human Pilot Study #2 (GLP-1-H24-2) ApprovedKELOWNA, BC / ACCESSWIRE / April 16, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(N...

Core News & Articles
Lexaria Appoints Nelson Cabatuan As Chief ...
03/14/2024 13:22:01

Lexaria Bioscience Corp.

why-asana-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Asana Shares Are Trading Lower By 11%?...
03/12/2024 18:07:31

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
03/12/2024 17:31:12

lexaria-bioscience-hires-contract-research-organization-to-perform-cos-next-glp-1-human-pilot-study
Lexaria Bioscience Hires Contract Research...
03/07/2024 14:08:10

maxim-group-maintains-buy-on-lexaria-bioscience-raises-price-target-to-12
Maxim Group Maintains Buy on Lexaria Biosc...
03/05/2024 16:41:51

Maxim Group analyst Michael Okunewitch maintains Lexaria Bioscience (NASDAQ:LEXX) with a Buy and raises the price target fro...

watching-lexaria-bioscience-traders-circulate-analyst-comments-suggesting-dehydratech-platform-for-the-delivery-of-glp-1-drugs-with-a-comprehensive-development-program-could-produce-a-compelling-data-package-to-partner-the-technology
Watching Lexaria Bioscience; Traders Circu...
03/05/2024 16:27:35

Core News & Articles
Lexaria To Begin Diabetes And Weight Loss ...
03/05/2024 14:10:01

Multiple DehydraTECH-GLP-1 and DehydraTECH-CBD formulations to be testedChronic dosing over a 12-week treatment periodWill asse...

lexaria-announces-fda-clearance-for-its-planned-us-phase-1b-hypertension-clinical-trial
Lexaria Announces FDA Clearance For Its Pl...
03/01/2024 13:22:01

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
02/28/2024 21:31:07

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)